Scientific publications

Comparaison indirecte à l’aide de données issues de la littérature : Application à une étude visant à valider la non-infériorité d’un nouveau dispositif médical à un dispositif standard dans la sécheresse oculaire

Date : 24/06/2024

Authors:

Wiederkehr S, Arafate I, Chapalain V, Paternotte S

Identifying effect of a treatment from observational data in absence of contemporaneous control – Example of the TOSCA study, comparing the efficacy of cemiplimab vs. Historical Systemic Treatment in Cutaneous Squamous Cell Carcinoma in France

Date : 03/08/2023

Authors:

Perrier S, Vataire A-L, Garnier S, Tabellion A, Lotz V , Lanoy E

Publication source

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study

Date : 06/03/2024

Authors:

Caroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, Marie-Sarah Dilhuydy, Bruno Anglaret, Borhane Slama, Katell Le Du, Stéphanie Tardy, Emmanuelle Tchernonog, Hubert Orfeuvre, Laurent Voillat, Stéphanie Guidez, Jean-Valère Malfuson, Sandrine Dupuis, Marine Deslandes, Pierre Feugier & Véronique Leblond on behalf of the FIRE Investigators Group

Publication source

Prevention of foot blisters using COMPEED® hydrocolloid plasters: a randomized, open-labelled comparative superiority clinical investigation versus regular plasters.

Date : 03/08/2023

Authors:

Zakka Bajjani J, Auzou P, James T, Katsogiannou M, Chapalain V, et al. (2023)

Publication source

A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance

Date : 08/11/2022

Authors:

Blivet G, Relano-Ginesa A, Wachtel M & Touchon J

Publication source

Ponatinib Long-Term Follow-up of Efficacy and Safety in CP-CML Patients in Real World Settings in France: the POST-PACE Study

Date : 01/05/2021

Authors:

Etienne G, Rea D, Coiteux V, Guerci-Bresler A, Huguet F, Legros L, Rousselot P & Nicolini FE

Publication source

Scientific and methodological consistency throughout a clinical study: How to succeed?

Date : 02/11/2020

Authors:

S. Wiederkehr, C. Rigault, V. Chapalain, R. Gauchoux – ICTA PM, Fontaine Lès Dijon

Amélioration de la qualité de vie et de la continence des patients atteints de RCH distale, traités par Mésalazine. Étude QUARTZ

Date : 25/09/2020

Authors:

Paupard T, Gonzalez F, Siprhoudhis L & Peyrin-Biroulet L

Publication source

Exploitation des Données de Vie Réelle Issues d’un Registre en Oncologie : Comment Identifier les Lignes de Chimiothérapie d’une Cohorte de Patientes Atteintes d’un Cancer Ovarien

Date : 18/09/2020

Authors:

J.Skrzypski, E.Yon, V.Chapalain, S.Wiederkehr, R.Gauchoux – ICTA PM, Fontaine Lès Dijon

Evolution of Hepatitis C Virus Treatment During the Era of Sofosbuvir-Based Therapies: A Real-World Experience in France.

Date : 18/04/2020

Authors:

Ouzan D, Larrey D, Guyader D, Remy AJ, Riachi G, Heluwaert F, Truchi R, Combis JM, Bailly F, Rosa I, Hézode C, Glorian-Petraud D, Libert O, Ramroth H, Asselah T, Thiefin G, Roulot D, Roche B, Leroy V, Dumortier J, Thabut D & Pol S; HELIOS study group.

Publication source

Improvement of Quality of life and continence in patients with distal ulcerative colitis treated by mesalazine. The QUARTZ study

Date : 12/02/2020

Authors:

Paupard T, Gonzalez F, Siprhoudhis L & Peyrin-Biroulet L

Publication source

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program

Date : 05/02/2020

Authors:

Robin C, Thiebaut A, Alain S, Sicre de Fontbrune F, Berceanu A, D’Aveni M, Ceballos P, Redjoul R, Nguyen-Quoc S, Bénard N, Pahlavan-Grumel G & Cordonnier C

Publication source

Ponatinib Long-Term Follow-up of Efficacy and Safety in CP-CML Patients in Real World Settings in France: The Post-PACE Study

Date : 12/09/2019

Authors:

Nicolini FE, Rea D, Coiteux V, Guerci-Bresler A, Huguet F, Karsenti JM, Legros L, Rousselot P & Etienne G

Phase 2 study results of Murlentamab, a monoclonal antibody targeting the anti-mullerian hormone receptor II (AMHRII), acting through tumor associated macrophage (TAM) engagement in advanced/metastatic colorectal cancer

Date : 03/07/2019

Authors:

Van Cutsem E, Melichar B, Van Den Eynde M, Prausova J, Geboes K, Dekervel J, Vitaskova D, De Cuyper A, Linke Z, Van Acker N, Frenois FX, Noël G, Prost JF, Barret JM, Jean B & Tabah-Fisch I

Publication source

Étude observationnelle, prospective décrivant les caractéristiques et la prise en charge de femmes atteintes d’une ostéoporose post-ménopausique traitées par Prolia® et son utilisation en pratique clinique courante en France (étude PILOTE)

Date : 01/06/2019

Authors:

Schott AM, Briot K, Sanchez P, Bendavid S, Bosquet L, Perot S, Etringer A, Chauny JV, Samama P & Désaméricq G

Publication source

First-in-human first-in-class phase I trial of Murlentamab, a an Anti-Müllerian-Hormone-Receptor II (AMHRII) monoclonal antibody acting through Tumor Associated Macrophage (TAM) engagement, as single agent and in combination with Carboplatin (C) and Paclitaxel (P) in AMHRII-expressing advanced/metastatic gynecological cancer patients (pts)

Authors:

Leary A, Awada A, Delord JP, Floquet A, Ray-Coquard I, Abdeddaim C, Fabbro M, Kalbacher E, Vergote I, Banerjee S, Frenois FX, Noel G, Lantz O, Cassard L, Coste A, Villard M, Lemée F, Tabah-Fisch I & Le Tourneau C

Publication source

No effect of alcohol consumption or dependence on treatment outcome in chronic hepatitis C patients treated with Elbasvir/Grazoprevir in real-world setting

Date : 10/04/2019

Authors:

Bronowicki JP, Miailhes P, Hanslik B, Abergel A, Larrey D, Pospait D, Truchi R, Ouzan D, Jouannaud V, Perrot S, Skrzypski J, Liautard C, Estrabaud E, Spampinato A, Guidoum A & Sogni P

Publication source

Letermovir for prophylaxis of Cytomegalovirus (CMV) infection or disease in allogeneic HCT recipients: experience of secondary prophylaxis in the French Compassionate program

Date : 24/03/2019

Authors:

Robin C, Thiebaut A, Alain S, Sicre de Fontbrune F, Berceanu A, D’Aveni M, Ceballos P, Redjoul R, Nguyen-Quoc S, Bénard N, Pahlavan-Grumel G & Cordonnier C

Premiers résultats de l’étude multicentrique prospective observationnelle avec l’association elbasvir/grazoprévir dans le traitement de l’hépatite chronique C en France : observatoire ZEPHYR

Date : 21/03/2019

Authors:

Bronowicki JP, Miailhes P, Hanslik B, Abergel A, Larrey D, Pospait D, Truchi R, Ouzan D, Riachi G, Skrzypski J, Guidoum A, Spampinato A & Sogni P

Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study, the TULIP study

Date : 14/03/2019

Authors:

Laribi K, Badinand D, Janoray P, Benabed K, Mouysset JL, Fabre E, Monchecourt F & Diab R

Publication source

Gaucher Disease: Baseline Preliminary Data of the French Eliglustat Patient Reported Outcome Study (ELIPRO)

Date : 04/02/2019

Authors:

Camou F, Gaches F, Cador-Rousseau B, Coutinho A, Belmatoug N & Berger MG

Publication source

Gaucher Disease: Baseline Preliminary Data of the French Eliglustat Patient Reported Outcome Study (ELIPRO)

Date : 04/02/2019

Authors:

Camou F, Gaches F, Cador-Rousseau B, Coutinho A, Belmatoug N & Berger MG

Publication source

Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.

Date : 26/01/2019

Authors:

El Cheikh J, Ceballos P, Dalle JH, Ducastelle-Leprêtre S, Dulon E & Herbrecht R

Publication source

Technique d’inhalation des sujets asthmatiques utilisant Duoresp Spiromax en condition de vie réelle.

Date : 25/01/2019

Authors:

Roch N, Aguilaniu B, Similowski T, Monchecourt F & Deveza P

Publication source

Results and validation of an index to measure health state of patients with depression in automated healthcare databases.

Date : 22/01/2019

Authors:

Lamy FX, Falissard B, François C, Lançon C, Llorca PM, Tanasescu A, Touya M, Verpillat P, Wade AG & Saragoussi D.

Publication source

The challenge of unexplained splenomegalies: preliminary data of the French prospective multi-center SplenoMegalyStudy (SMS)

Date : 29/11/2018

Authors:

Denis G, Sanhes L, Ziza JM, Bauduer F, Berger MG, Costello RT, Mehdi K, Michaud M, Urbanski G & Rose C

Publication source

Etude multicentrique prospective observationnelle de l’association elbasvir/grazoprévir dans le traitement de l’hépatite chronique C en France : observatoire zephyr

Date : 01/10/2018

Authors:

Bronowicki JP, Miailhes P, Hanslik B, Abergel A, Larrey D, Pospait D, Truchi R, Ouzan D, Vernier-Faudot E, Skrzypski J, Guidoum A, Spampinato A & Sogni P

Publication source

Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study

Date : 10/08/2018

Authors:

Garaix F, Stern M, Lamy FX, Dubel L & Kamar N.

Publication source

Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study.

Date : 09/06/2018

Authors:

Gangneux JP, El Cheikh J, Herbrecht R, Yakoub-Agha I, Quiniou JB, Caillot D & Michallet M

Publication source

A First-In-Human study of monoclonal antibody GM102 in patients in patients with Anti Anti -Müllerian -Hormone -Receptor II (AMHRII) positive gynecological cancers

Date : 01/06/2018

Authors:

Leary A, Aftimos PG, Delord JP, Le Tourneau C, Ray-Coquard IL, Jungels C, Varga A, Ricci F, Gomez-Roca CA, Bataillon G, Van Acker N, Noël G, Lantz O, Cassard L, Coste A, Jean B, Tabah-Fisch IM, Vincent-Salomon A, Prost JF & Awada A

Publication source

Prospective evaluation of the effect of deferasirox on hematologic response in transfusion-dependent patients with low-risk MDS and iron overload.

Date : 02/05/2018

Authors:

Rose C, Lenoir C, Gyan E, Hacini M, Amé S, Corront B, Beyne-Rauzy O, Adiko D, Loppinet E, Ali-Ammar N, Laribi K, Wattel E, Dreyfus F, Roué CS & Cheze S

Publication source

Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study

Date : 01/05/2018

Authors:

Picard F, Ducrocq G, Danchin N, Falissard B, Hanon O, Mahe I, Touzé E & Steg PG

Publication source

An Auto-Adjustable Night Garment to Control Early Rebound Effect of Edema Volume After Intensive Phase of Decongestive Lymphedema Therapy

Date : 01/12/2017

Authors:

Mestre S, Gaillard G, Benhamou M, Soulier-Sotto V, Nou M, Pasqualini M, Amor CB & Quere I.

Publication source

Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology

Date : 13/09/2017

Authors:

François C, Tanasescu A, Lamy FX, Despiegel N, Falissard B, Chalem Y, Lançon C, Llorca PM, Saragoussi D, Verpillat P, Wade AG & Zighed DA

Publication source

Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children.

Date : 16/08/2017

Authors:

Leger D, Bonnefoy B, Pigearias B, de La Giclais B & Chartier A

Publication source

Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM® Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT.

Date : 09/03/2017

Authors:

Mestre S, Calais C, Gaillard G, Nou M, Pasqualini M, Ben Amor C & Quere I.

Publication source